The bleeding time is performed to evaluate the platelet interaction with th
e vessel wall. It is a helpful clinical tool to detect and investigate cert
ain hemostatic defects in neonates and to evaluate the adequacy of treatmen
ts. A prolonged bleeding time indicates either a quantitative or qualitativ
e platelet disorder or microvascular defectiveness. Platelet hyporeactivity
in the first days of life, gestational age, platelet dysfunction secondary
to various neonatal or maternal pathologic conditions, neonatal or materna
l drug administration, and hematocrit must be considered for the correct in
terpretation of the bleeding time test in neonates.